Literature DB >> 26108016

Quality assessment of clinical practice guidelines for Chagas disease.

Mario Javier Olivera1, Johana Alexandra Fory2, Antonio José Olivera3.   

Abstract

INTRODUCTION: The development of clinical practice guidelines (CPGs) has increased; this study aimed to assess the quality of CPGs for the management of Chagas disease.
METHODS: Following a systematic search of the scientific literature, two reviewers assessed the eligible guidelines using the Appraisal of Guidelines Research and Evaluation (AGREE) II instrument.
RESULTS: Five CPGs were included. The AGREE domains of scope/purpose, stakeholder involvement, and clarity of presentation were rated well, and the domains of applicability and editorial independence received poor ratings.
CONCLUSIONS: The quality of CPGs for Chagas disease is poor, and significant work is required to develop high-quality guidelines.

Entities:  

Mesh:

Year:  2015        PMID: 26108016     DOI: 10.1590/0037-8682-0251-2014

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  3 in total

1.  Barriers to Diagnosis Access for Chagas Disease in Colombia.

Authors:  Mario Javier Olivera; Julián Felipe Porras Villamil; Christian Camilo Toquica Gahona; Jorge Martín Rodríguez Hernández
Journal:  J Parasitol Res       Date:  2018-02-07

2.  Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease.

Authors:  Mario J Olivera; Zulma M Cucunubá; Carlos A Valencia-Hernández; Rafael Herazo; Diana Agreda-Rudenko; Carolina Flórez; Sofía Duque; Rubén S Nicholls
Journal:  PLoS One       Date:  2017-09-26       Impact factor: 3.240

3.  Prevalence of Chagas disease in Colombia: A systematic review and meta-analysis.

Authors:  Mario J Olivera; Johana A Fory; Julián F Porras; Giancarlo Buitrago
Journal:  PLoS One       Date:  2019-01-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.